AprilBio Co.,Ltd.

₩10,700As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:397030Healthcare
Country South Korea
PE (Fwd) •••
TSR 4Y CAGR (0.59%)
Div yield —
ROE (9.65%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 1.78
PE TTM —
TSR TTM (67.67%)
Mkt cap ₩294.3B
ROIC (6.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩13,053
21.99%
(32.48%)
Hold 6|11|4|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
144.29
150.17
147.79
155.96
11.30%
16.35%
5.70%
3.25%
Revenue₩B
18.07
18.57
18.38
19.40
7.12%
6.13%
(0.43%)
6.89%
Peers (US$217.0M)
Cap (US$)
PE
236.3M
—
222.5M
—
Capital
TTM
5Y
10Y
Leveragex
0.298
0.043
0.037
EBIT/Intx
1.117
0.450
0.448
Own earn%
308.36
48.76
33.87
Sh yield%
27.11
33.10
33.00
Owners
Insiders/Inst%
4.82
32.08
Short interest%
5.24
SBC / revenue%
2.72
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
27–30
$1 testx
0.2
Incr. ROIC%
7